COuGH RefluX评分在咽喉反流症状患者中的实际应用:预测胃食管反流病及质子泵抑制剂反应的现实世界评估
研究前瞻性纳入196例咽喉反流症状超过3个月的患者,用COuGH RefluX评分分组并评估质子泵抑制剂反应。结果显示评分越高,胃食管反流病可能性及质子泵抑制剂反应率越高,评分和夜间基线阻抗均值是质子泵抑制剂反应的独立预测因素。
要点
- COuGH RefluX评分可能组(≥5.0分)质子泵抑制剂反应率为73.3%,高于不确定组45.0%和不可能组12.4%。
- 评分3.0-4.5分(OR=4.190)和≥5.0分(OR=15.772)是质子泵抑制剂反应的独立预测因素。
- 夜间基线阻抗均值较低(OR=0.915)也是质子泵抑制剂反应的独立预测因素。
核心结论
- COuGH RefluX评分可有效预测无食管炎咽喉反流症状患者的胃食管反流病并指导质子泵抑制剂使用。
研究设计与样本
- 前瞻性研究,纳入196例咽喉反流症状超过3个月的患者,平均年龄47.8岁。
- 使用反流症状指数和24小时阻抗-pH监测评估,按COuGH RefluX评分分为不可能胃食管反流病(≤2.5分)、不确定(3.0-4.5分)和可能(≥5.0分)三组。
- 质子泵抑制剂反应定义为反流症状指数降低50%。
主要发现
- 196例中,121例为不可能胃食管反流病,60例为不确定,15例为可能。
- 不可能胃食管反流病组较不确定和可能组有更高的夜间基线阻抗均值、更低食管裂孔疝患病率和更少确诊胃食管反流病病例(P<0.05)。
- 症状严重程度和酸暴露时间在三组间相似(P>0.05)。
- 质子泵抑制剂反应率在三组分别为12.4%、45.0%和73.3%(P<0.001)。
- 多因素logistic回归显示COuGH RefluX评分和较低夜间基线阻抗均值是质子泵抑制剂反应的独立预测因素(评分3.0-4.5分,OR=4.190,P=0.001;评分≥5.0分,OR=15.772,P<0.001;夜间基线阻抗均值,OR=0.915,P=0.001)。
临床怎么用
- 作者认为COuGH RefluX评分可确保咽喉反流症状患者初次就诊时质子泵抑制剂的合理使用和针对性检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The COuGH RefluX score has been validated to predict likelihood of gastroesophageal reflux disease (GERD) in patients with laryngopharyngeal symptoms (LPS) using parameters of cough, overweight, globus, hiatal hernia, regurgitation, and male sex. The aim of this study was to assess the real-world value of the COuGH RefluX score in predicting proton-pump inhibitor (PPI) response in patients with LPS. METHODS: Patients with LPS for > 3 months were prospectively enrolled and assessed using the Reflux Symptom Index and 24-hour impedance-pH monitoring. Based on COuGH RefluX scores, patients were designated unlikely GERD (≤ 2.5), inconclusive GERD (3.0-4.5), and likely GERD (≥ 5.0). PPI response was defined as a 50% reduction in Reflux Symptom Index. RESULTS: Among 196 participants (mean age 47.8 years), 121 were unlikely, 60 were inconclusive, and 15 were likely to have GERD. Patients unlikely to have GERD had higher mean nocturnal baseline impedance (MNBI), lower hiatal hernia prevalence, and fewer confirmed GERD cases compared with inconclusive and likely GERD groups ( P < 0.05). Symptom severity and acid exposure time were similar across groups ( P > 0.05). PPI response rates were 12.4%, 45.0%, and 73.3% across the groups ( P < 0.001). Multivariate logistic regression showed COuGH RefluX scores and lower MNBI as independent predictors of PPI responsiveness (scores 3.0-4.5, odds ratio (OR) = 4.190, P = 0.001; scores ≥5.0, OR = 15.772, P < 0.001; MNBI, OR = 0.915, P = 0.001). DISCUSSION: The COuGH RefluX score is effective in predicting GERD and guiding PPI use in patients with LPS without esophagitis. The score can ensure appropriate PPI use and targeted testing during initial LPS patient encounters.
引用
- Wong MW, Hsiao SH, Wang JH, et al. Practical Application of the COuGH RefluX Score for Patients With Laryngopharyngeal Symptoms: Real-World Assessment in Predicting Gastroesophageal Reflux Disease and Proton-Pump Inhibitor Response. Am J Gastroenterol. 2024. PMID: 39589005. doi:10.14309/ajg.0000000000003240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。